<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Although <z:chebi fb="25" ids="22693">barbiturates</z:chebi> are considered to be cerebral protectants, little is known regarding the relative efficacy of different <z:chebi fb="25" ids="22693">barbiturates</z:chebi> to reduce ischemic brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>In a model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo), we compared the relative effects of 1.0 and 0.4 burst-suppression doses of thiopentone, <z:chebi fb="0" ids="102216">methohexital</z:chebi>, and <z:chebi fb="1" ids="7983">pentobarbitone</z:chebi> on cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: During <z:chebi fb="0" ids="6015">isoflurane</z:chebi> anesthesia, MCAo was achieved via a temporal craniotomy </plain></SENT>
<SENT sid="3" pm="."><plain>Thirty minutes before MCAo the rats were randomized to receive one of the following which was maintained throughout the study </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="2" ids="5615">Halothane</z:chebi> (n=20)-1.2 MAC <z:chebi fb="2" ids="5615">halothane</z:chebi>, thiopentone (n=20), <z:chebi fb="0" ids="102216">methohexital</z:chebi> (n=20), or <z:chebi fb="1" ids="7983">pentobarbitone</z:chebi> (n=20) </plain></SENT>
<SENT sid="5" pm="."><plain>The first ten animals in each <z:chebi fb="8" ids="29745">barbiturate</z:chebi> group received the respective <z:chebi fb="8" ids="29745">barbiturate</z:chebi> in a dose sufficient to maintain burst-suppression of the electroencephalogram (3-5 bursts x min(-1)) </plain></SENT>
<SENT sid="6" pm="."><plain>The subsequent ten animals in each <z:chebi fb="8" ids="29745">barbiturate</z:chebi> group received 40% of the burst-suppression dose </plain></SENT>
<SENT sid="7" pm="."><plain>After 180 min of MCAo and 120 min of reperfusion, cerebral injury was assessed </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: For the burst-suppression animals, injury volume (mm3, mean +/- SD) was less in the thiopentone group (88 +/- 14) than the <z:chebi fb="2" ids="5615">halothane</z:chebi> (133 +/- 17), <z:chebi fb="0" ids="102216">methohexital</z:chebi> (126 +/- 19), or <z:chebi fb="1" ids="7983">pentobarbitone</z:chebi> (130 +/- 17) groups (P &lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>For 0.4 burst-suppression animals, injury volume was less for the <z:chebi fb="0" ids="102216">methohexital</z:chebi> group (70 +/- 22) than the <z:chebi fb="2" ids="5615">halothane</z:chebi> (124 +/- 24), thiopentone (118 +/- 15), or <z:chebi fb="1" ids="7983">pentobarbitone</z:chebi> (121 +/- 20) groups (P &lt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These data are inconsistent with the longstanding assumption that electrophysiologically comparable doses of the various classes of <z:chebi fb="25" ids="22693">barbiturates</z:chebi> have equivalent protective efficacy </plain></SENT>
<SENT sid="11" pm="."><plain>They in turn suggest that mechanisms other than, or at least in addition to, metabolic suppression may contribute to the protective effect of <z:chebi fb="25" ids="22693">barbiturates</z:chebi> </plain></SENT>
</text></document>